Airway Involvement In Inflammatory Bowel Disease

NCT ID: NCT06090045

Last Updated: 2023-10-19

Basic Information

• Recruitment Status: UNKNOWN
• Total Enrollment: 70 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2023-11-20
• Study Completion Date: 2024-12-25

Brief Summary

To estimate prevalence of subclinical airway injuries among IBD patients. To investigate relationship between activity of IBD and airways

Detailed Description

Airway diseases are the most commonly described lung manifestations of inflammatory bowel disease (IBD). However, the similarities in disease pathogenesis and the sharing of important environmental risk factors and genetic susceptibility suggest that there is a complex interplay between IBD and airway diseases.Extraintestinal manifestations (EIM) commonly occur in inflammatory bowel diseases (IBD), with a prevalence rate between 21%-41% reported in various series. Crohn's disease (CD) presents with EIM more frequently than ulcerative colitis (UC). Pulmonary involvement complicating IBD was originally considered rare (with a frequency rate < 1%), but the first case series published in 1976 assisted in better recognition, evaluation and description of IBD related respiratory disease. Pulmonary involvement is often asymptomatic and may be detected solely on the basis of abnormal screening tests. This review will focus on the involvement of the airways in the context of IBD. Although IBD related PM were originally considered rare, certain population-based studies have revealed significant interrelationships between the lungs and IBD. Bernstein and colleagues in a large population-based study in North America in 2005 reported that airway disorders in general (including asthma and bronchitis) were the most common extraintestinal manifestation in subjects with CD and the second most common in subjects with UC, with the prevalence of asthma in this population between 7%-8%. In another retrospective study from the opposite view, Birring reported that IBD was 4 times more prevalent among patients with airway diseases, particularly non-asthmatic patients with productive cough, than in the general population.

Conditions

IBD

Study Design

• Observational Model Type: COHORT
• Study Time Perspective: PROSPECTIVE

Eligibility Criteria

Inclusion Criteria

• Patients attended to IBD clinic at Tropical Department

Exclusion Criteria

1. Age: less than 18 years

2. Unstable patients or need for ICU admission

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 70 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Assiut University

OTHER

Sponsor Role: lead

Responsible Party

Hend Mohamed Sayed Mohamed

Lecture

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Marwa Salama, MD

Role: STUDY_CHAIR

Assiut University

Central Contacts

Hend Saleh, MD

Role: CONTACT

hend.m.saleh@gmail.com

01098987812

Nermen Abuelkassem, MD

Role: CONTACT

Nermenabuelkassem@gmail.com

0100076713

References

Vutcovici M, Brassard P, Bitton A. Inflammatory bowel disease and airway diseases. World J Gastroenterol. 2016 Sep 14;22(34):7735-41. doi: 10.3748/wjg.v22.i34.7735.

Reference Type: BACKGROUND

PMID: 27678355 (View on PubMed)

Byrd KM, Gulati AS. The "Gum-Gut" Axis in Inflammatory Bowel Diseases: A Hypothesis-Driven Review of Associations and Advances. Front Immunol. 2021 Feb 19;12:620124. doi: 10.3389/fimmu.2021.620124. eCollection 2021.

Reference Type: BACKGROUND

PMID: 33679761 (View on PubMed)

Other Identifiers

IBD&Airway

Identifier Type: -

Identifier Source: org_study_id